Suppr超能文献

吸入炭疽杆菌可导致小鼠患肺动脉高压。

Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice.

作者信息

Ochiai Eri, Kamei Katsuhiko, Watanabe Akira, Nagayoshi Masaru, Tada Yuji, Nagaoka Tetsutaro, Sato Koichi, Sato Ayaka, Shibuya Kazutoshi

机构信息

Department of Pathogenic Fungi, Medical Mycology Research Center, Chiba University, Chiba, Japan.

出版信息

Int J Exp Pathol. 2008 Jun;89(3):201-8. doi: 10.1111/j.1365-2613.2008.00585.x.

Abstract

Inhalation of Stachybotrys chartarum, a ubiquitous fungus in our living environment, has been suspected as a cause of acute idiopathic pulmonary haemorrhage in infants, but its relation to human diseases is not yet known. The aim of present study was to investigate the effect of repeated intratracheal injection of the fungus into mice, paying special attention to the pulmonary vascular system. Spores of S. chartarum were injected into the trachea of mice from 6 to 18 times over 4-12 weeks, and the lungs were examined by histopathology, morphometrics and haemodynamics. When 1 x 10(4) spores/mouse were injected, histopathological examination showed the development of pulmonary arterial hypertension (PAH). Symmetrical thickening of the intima and media of the pulmonary arterial walls was seen after six injections over 4 weeks. Right ventricular hypertrophy was also evident after 12 injections. PAH was confirmed by the elevation of right ventricular systolic pressure (20.1 +/- 5.7 mmHg in the injected group vs. 12.0 +/- 2.4 mmHg in the control group, P < 0.01). This study showed that the inhalation of S. chartarum caused PAH in mice, suggesting a potential of S. chartarum as a cause of human health problem such as PAH.

摘要

吸入我们生活环境中普遍存在的真菌——黑曲霉,被怀疑是婴儿急性特发性肺出血的一个病因,但其与人类疾病的关系尚不清楚。本研究的目的是调查向小鼠反复气管内注射该真菌的影响,特别关注肺血管系统。在4至12周内,将黑曲霉孢子注入小鼠气管6至18次,然后通过组织病理学、形态计量学和血流动力学对肺进行检查。当每只小鼠注射1×10(4)个孢子时,组织病理学检查显示出现了肺动脉高压(PAH)。在4周内注射6次后,可见肺动脉壁内膜和中膜对称增厚。注射12次后右心室肥厚也很明显。通过右心室收缩压升高证实了PAH(注射组为20.1±5.7 mmHg,对照组为12.0±2.4 mmHg,P<0.01)。本研究表明,吸入黑曲霉可导致小鼠发生PAH,提示黑曲霉有可能成为人类PAH等健康问题的一个病因。

相似文献

1
Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice.
Int J Exp Pathol. 2008 Jun;89(3):201-8. doi: 10.1111/j.1365-2613.2008.00585.x.
2
Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor.
Mycopathologia. 2011 Jul;172(1):5-15. doi: 10.1007/s11046-011-9400-3. Epub 2011 Apr 20.
3
Reduction of pulmonary toxicity of Stachybotrys chartarum spores by methanol extraction of mycotoxins.
Appl Environ Microbiol. 2000 Jul;66(7):2817-21. doi: 10.1128/AEM.66.7.2817-2821.2000.
4
Pulmonary effects of Stachybotrys chartarum in animal studies.
Adv Appl Microbiol. 2004;55:241-73. doi: 10.1016/S0065-2164(04)55009-8.
6
Inhalation of Fragments Induces Pulmonary Arterial Remodeling.
Am J Respir Cell Mol Biol. 2020 May;62(5):563-576. doi: 10.1165/rcmb.2019-0221OC.
7
The Pathogenicity of Stachybotrys chartarum.
Nihon Ishinkin Gakkai Zasshi. 2005;46(2):109-17. doi: 10.3314/jjmm.46.109.
9
Cultivation and aerosolization of for modeling pulmonary inhalation exposure.
Inhal Toxicol. 2019 Nov-Dec;31(13-14):446-456. doi: 10.1080/08958378.2019.1705939. Epub 2019 Dec 24.

引用本文的文献

1
Cultivation and aerosolization of for modeling pulmonary inhalation exposure.
Inhal Toxicol. 2019 Nov-Dec;31(13-14):446-456. doi: 10.1080/08958378.2019.1705939. Epub 2019 Dec 24.
2
Inhalation of Fragments Induces Pulmonary Arterial Remodeling.
Am J Respir Cell Mol Biol. 2020 May;62(5):563-576. doi: 10.1165/rcmb.2019-0221OC.
4
Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.
Int J Exp Pathol. 2016 Jun;97(3):238-47. doi: 10.1111/iep.12166. Epub 2016 Jul 1.
5
Repeated Mouse Lung Exposures to Stachybotrys chartarum Shift Immune Response from Type 1 to Type 2.
Am J Respir Cell Mol Biol. 2016 Oct;55(4):521-531. doi: 10.1165/rcmb.2015-0291OC.
7
Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor.
Mycopathologia. 2011 Jul;172(1):5-15. doi: 10.1007/s11046-011-9400-3. Epub 2011 Apr 20.
8
Guest editorial--novel insights into the pathology of Stachybotrys chartarum.
Mycopathologia. 2011 Jul;172(1):1-3. doi: 10.1007/s11046-011-9426-6. Epub 2011 Apr 20.

本文引用的文献

1
Rodent models of PAH: are we there yet?
Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L580-2. doi: 10.1152/ajplung.00281.2007. Epub 2007 Jul 27.
2
Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.
Am J Pathol. 2007 Sep;171(3):790-9. doi: 10.2353/ajpath.2007.070178. Epub 2007 Jul 19.
3
Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
Circ Res. 2007 Mar 30;100(6):923-9. doi: 10.1161/01.RES.0000261658.12024.18. Epub 2007 Mar 1.
5
Strain differences influence murine pulmonary responses to Stachybotrys chartarum.
Am J Respir Cell Mol Biol. 2006 Oct;35(4):415-23. doi: 10.1165/rcmb.2005-0483OC. Epub 2006 May 11.
6
Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Circ Res. 2006 May 26;98(10):1323-30. doi: 10.1161/01.RES.0000222546.45372.a0. Epub 2006 Apr 13.
7
Pulmonary arterial hypertension.
Ann Med. 2006;38(2):95-110. doi: 10.1080/07853890600622143.
8
A review of tribromoethanol anesthesia for production of genetically engineered mice and rats.
Lab Anim (NY). 2005 Nov;34(10):47-52. doi: 10.1038/laban1105-47.
9
The Pathogenicity of Stachybotrys chartarum.
Nihon Ishinkin Gakkai Zasshi. 2005;46(2):109-17. doi: 10.3314/jjmm.46.109.
10
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
FASEB J. 2005 Jul;19(9):1175-7. doi: 10.1096/fj.04-3223fje. Epub 2005 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验